Neoadjuvant Chemoradiation
Also known as: Neoadjuvant Chemoradiation Therapy / Neoadjuvant Chemoradiotherapy
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB09035 | Nivolumab | A PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB09035 | Nivolumab | Programmed cell death protein 1 | target |
| DB09035 | Nivolumab | Programmed cell death 1 ligand 1 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01101 | Capecitabine | 3 | Unknown Status | 1 |
| DB00526 | Oxaliplatin | 3 | Unknown Status | 1 |
| DB01101 | Capecitabine | Not Available | Unknown Status | 1 |
| DB00526 | Oxaliplatin | Not Available | Unknown Status | 1 |